Company intelligence / Profile preview

OKRA.ai

Cambridge, Cambridgeshire, United Kingdom

Ownership: Private
Employees: ~50
Development stage: Other

Overview

OKRA.ai is a leading artificial intelligence company specializing in the life sciences sector. The company provides an AI-driven platform that transforms complex healthcare data into actionable insights for medical affairs, commercial, and market access teams. Their technology utilizes explainable AI to help pharmaceutical companies predict market trends, optimize product performance, and improve patient outcomes. In February 2023, OKRA.ai was acquired by Envision Pharma Group to integrate advanced predictive analytics into Envision's suite of medical and commercial solutions.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

AstraZenecaBayerBristol Myers Squibb

Beyond the preview

Go deeper on OKRA.ai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OKRA.ai.

Explore the full profile